Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2721)	8/2/1999 1:24:00 AM
From: Druss	Read Replies (1) \| Respond to of 10293

Dan--You have more knowledge of the field than I do. I was not seeking to say that specific companies are going to compete with GUMM. I was offering my observation that competition tends to arise in generic drugs. Generic drugs tend to be low margin because of this. GUMM may very well rule the field of generic nicotine gum but I suspect if there is a huge market other players will enter. From a personal perspective from my own market experience I would not count on it being hugely profitable but this specific area I have not done extensive DD on, my comments were general in terms of how I have seen generic drug manufacturers do. All the Best Druss